Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
autologous skeletal myoblast (3 trials)
allogeneic adipose derived mesenchymal stem cell (2 trials)
platelet-rich plasma (1 trial)
autologous adipose-derived mesenchymal stem cells (1 trial)
Coronary Artery Disease (Phase 1)
Heart Failure (Phase 3)
Infarction (Phase 3)
Myocardial Infarction (Phase 3)
Osteoarthritis (Phase 1)
Trials (6 total)
Trial APIs (4 total)